Biomonitoring Equivalents (BE) dossier for 2,4-dichlorophenoxyacetic acid (2,4-D) (CAS No. 94-75-7)

Regulatory Toxicology and Pharmacology

Volumn 51, Issue 3 SUPPL., 2008, Pages

  Aylward, Lesa L ^a   Hays, Sean M ^a  

^a LLP   (United States)

Author keywords

2,4 Dichlorophenoxyacetic acid; BEs; Biomarkers; Biomonitoring; Biomonitoring Equivalents; Screening

Indexed keywords

2,4 DICHLOROPHENOXYACETIC ACID;

ALCOHOL CONSUMPTION; ARTICLE; BIOLOGICAL MONITORING; BLOOD LEVEL; BLOOD SAMPLING; BLOOD TOXICITY; CARCINOGENICITY; CHRONIC TOXICITY; CONCENTRATION (PARAMETERS); DRUG USE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL PROTECTION; GAIT DISORDER; GASTROINTESTINAL TOXICITY; GENETIC VARIABILITY; HUMAN; HYDRATION; KINETICS; LIVER TOXICITY; NEPHROTOXICITY; NEUROTOXICITY; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RISK ASSESSMENT; SKELETON MALFORMATION; SMOKING; UNCERTAINTY; UNITED STATES; URINALYSIS; URINARY EXCRETION; URINE LEVEL;

2,4-DICHLOROPHENOXYACETIC ACID; ANIMALS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; GUIDELINES AS TOPIC; HERBICIDES; HUMANS; MODELS, BIOLOGICAL; RISK ASSESSMENT;

EID: 47549116949     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2008.05.006     Document Type: Article

References (27)

1. Barr D.B., Wilder L.C., Caudill S.P., Gonzalez A.J., Needham L.L., and Pirkle J.L. Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ. Health Perspect. 113 (2005) 192-200
2. Bradberry S.M., Watt B.E., Proudfoot A.T., and Vale J.A. Mechanisms of toxicity, clinical features, and management of acute chlorophenoxy herbicide poisoning: a review. J. Toxicol. Clin. Toxicol. 38 (2000) 111-122
3. Centers for Disease Control and Prevention (CDC), 2005. Third National Report on Human Exposure to Environmental Chemicals. NCEH Pub. No. 05-0570. National Center for Environmental Health, Division of Laboratory Sciences, Atlanta, Georgia 30341-3724, USA.
4. Garde A.H., Hansen A.M., Kristiansen J., and Knudsen L.E. Comparison of uncertainties related to standardization of urine samples with volume and creatinine concentration. Ann. Occup. Hygiene 2 (2004) 171-179
5. Hays S.M., Becker R.A., Leung H.W., Aylward L.L., and Pyatt D.W. Biomonitoring equivalents: a screening approach for interpreting biomonitoring results from a public health risk perspective. Regul. Toxicol. Pharmacol. 47 (2007) 96-109
6. Hays S.M., Aylward L.L., LaKind J.S., Bartels M.J., Barton H.A., Boogaard P.J., Brunk C., DiZio S., Dourson M., Goldstein D.A., Lipscomb J., Kilpatrick M.E., Krewski D., Krishnan K., Nordberg M., Okino M., Tan Y.-M., Viau C., and Yager J.W. Guidelines for the derivation of biomonitoring equivalents: report from the Biomonitoring Equivalents Expert Workshop. Regul. Toxicol. Pharmacol. 51 (2008) S4-S15
7. Kerb R. Implications of genetic polymorphisms in drug transporters for pharmacotherapy. Cancer Letters 234 (2006) 4-33
8. Kim C.S., Binienda Z., and Sandberg J.A. Construction of a physiologically based pharmacokinetic model for 2,4-dichlorophenoxyacetic acid dosimetry in the developing rabbit brain. Toxicol. Appl. Pharmacol. 136 (1996) 250-259
9. Kim C.S., Gargas M.L., and Andersen M.E. Pharmacokinetic modeling of 2,4-dichlorophenoxyacetic acid (2,4-D) in rat and in rabbit brain following single dose administration. Toxicol. Lett. 74 (1994) 189-201
10. Kim C.S., Sandberg J.A., Slikker W., Binienda Z., Schlosser P.M., and Patterson T.A. Quantitative exposure assessment: application of physiologically-based pharmacokinetic (PBPK) modeling of low-dose, long-term exposures of organic acid toxicant in the brain. Environ. Toxicol. Pharmacol. 9 (2001) 153-160
11. Kim C.S., Slikker Jr. W., Binienda Z., Gargas M.L., and Andersen M.E. Development of a physiologically based pharmacokinetic model for 2,4-dichlorophenoxyacetic acid dosimetry in discrete areas of the rabbit brain. Neurotoxicol. Teratol. 17 (1995) 111-120
12. Kissel J.C., Curl C.L., Kedan G., Lu C., Griffith W., Barr D.B., Needham L.L., and Fenske R.A. Comparison of organophosphorus pesticide metabolite levels in single and multiple daily urine samples collected from preschool children in Washington state. J. Expos. Anal. Environ. Epidemiol. 15 (2005) 164-171
13. Knopp D. Assessment of exposure to 2,4-dichlorophenoxyacetic acid in the chemical industry: results of a five year biological monitoring study. Occup. Environ. Med. 51 (1994) 152-159
14. Knopp D., and Glass S. Biological monitoring of 2,4-dichlorophenoxyacetic acid-exposed workers in agriculture and forestry. Int. Arch. Occup. Environ. Health 63 (1991) 329-333
15. Kohli J.D., Khanna R.N., Gupta B.N., Dhar M.M., Tandon J.S., and Sircar K.P. Absorption and excretion of 2,4-dichlorophenoxyacetic acid in man. Xenobiotica 4 (1974) 97-100
16. LaKind J.S., Aylward L.L., Brunk C., DiZio S., Dourson M., Goldstein D.A., Kilpatrick M.E., Krewski D., Bartels M.J., Barton H.A., Boogaard P.J., Lipscomb J., Krishnan K., Nordberg M., Okino M., Tan Y.-M., Viau C., Yager J.W., and Hays S.M. Guidelines for the communication of Biomonitoring Equivalents: Report from the Biomonitoring Equivalents Expert Workshop. Regul. Toxicol. Pharmacol. 51 (2008) S16-S26
17. Mage D.T., Allen R.H., Gondy G., Smith W., Barr D.B., and Needham L.L. Estimating pesticide dose from urinary pesticide concentration data by creatinine correction in the Third National Health and Nutrition Examination Survey (NHANES-III). J. Expo. Anal. Environ. Epidemiol. 14 (2004) 457-465
18. O'Rourke M.K., Lizardi P.S., Rogan S.P., Freeman N.C., Aguirre A., and Saint C.G. Pesticide exposure and creatinine variation among young children. J. Expo. Anal. Environ. Epidemiol. 10 (2000) 672-681
19. Perucca J., Bouby N., Valeix P., and Bankir L. Sex difference in urine concentration across differing ages, sodium intake, and level of kidney disease. Am. J. Physiol. Regul. Integr. Comp. Physiol. 292 (2007) R700-R705
20. Remer T., Neubert A., and Maser-Gluth C. Anthropometry-based reference values for 24-h urinary creatinine excretion during growth and their use in endocrine and nutritional research. Am. J. Clin. Nutr. 75 (2002) 561-569
21. Remer T., Fonteyn N., Alexy U., and Berkemeyer S. Longitudinal examination of 24-h urinary iodine excretion in schoolchildren as a sensitive, hydration status-independent research tool for studying iodine status. Am. J. Clin. Nutr. 83 (2006) 639-646
22. Saghir S.A., Mendrala A.L., Bartels M.J., Day S.J., Hansen S.C., Sushynski J.M., and Bus J.S. Strategies to assess systemic exposure of chemicals in subchronic/chronic diet and drinking water studies. Toxicol. Appl. Pharmacol. 211 (2006) 245-260
23. Sauerhoff M.W., Braun W.H., Blau G.E., and Gehring P.J. The fate of 2,4-dichlorophenoxyacetic acid (2,4-D) following oral administration to man. Toxicology 8 (1977) 3-11
24. Scher D.P., Alexander B.H., Adgate J.L., Eberly L.E., Mandel J.S., Acquavella J.F., Bartels M.J., and Brzak K.A. Agreement of pesticide biomarkers between morning void and 24-h urine samples from farmers and their children. J. Exp. Sci. Environ. Epidemiol. 17 (2007) 350-357
25. Timchalk C. Comparative inter-species pharmacokinetics of phenoxyacetic acid herbicides and related organic acids. Evidence that the dog is not a relevant species for evaluation of human health risk. Toxicology 200 (2004) 1-19
26. United States Environmental Protection Agency (USEPA), 2004. Memorandum: 2,4-D-Second Report of the Hazard Identification Assessment Review Committee, TXR-0052303. Office of Prevention, Pesticides, and Toxic Substances.
27. van Ravenzwaay B., Hardwick T.D., Needham D., Pethen S., and Lappin G.J. Comparative metabolism of 2,4-dichlorophenoxyacetic acid (2,4-D) in rat and dog. Xenobiotica 33 (2003) 805-821